Data reuse enables cost-efficient randomized trials of medical AI models

Michael Nercessian, Wenxin Zhang, Alexander Schubert +4

Randomized controlled trials (RCTs) are indispensable for establishing the clinical value of medical artificial-intelligence (AI) tools, yet their high cost and long timelines hind…